Search results
Results from the WOW.Com Content Network
Merck’s (NYSE: MRK) Q1 2024 results reflect continued strong growth in oncology and vaccines. Our company announced Q1 worldwide sales of $15.8 billion, an increase of 9% from Q1 2023. “Merck has begun 2024 with continuing momentum in our business.
Explore Merck's investor events and presentations. Merck is the world's premier research-intensive, purpose-driven biopharmaceutical company.
Welcome to Investor Relations at Merck. Here you’ll find everything you might be interested in if you like to be invested in vibrant science and technology, and become or stay part of the Merck investor community.
The investors' section of Merck provides everything shareholders and potential investors need to know about the company. Read more Investor Relations
We organize a number of events to get in touch with our shareholders and keep them up-to-date on Merck and its businesses. Find all upcoming dates as well as webcasts and presentations of previous events here.
Contact investor relations. (732) 594-1468. investor_relations@merck.com. Explore our quarterly reports, annual reports & proxy. Merck is the world's premier research-intensive biopharmaceutical company.
Fourth-Quarter and Full-Year Sales Reflect Sustained Growth Across Oncology and Vaccines. Fourth-Quarter Worldwide Sales Were $14.6 Billion, an Increase of 6% From Fourth Quarter 2022;...
At our Capital Market Days, our shareholders have the opportunity to meet our management and gain insights into our success story. We inform investors about our strategy, the latest financial developments and about our plans for the future.
Lynparza1 sales grew 8% driven primarily by pricing in the U.S. and higher demand in international markets. Lenvima2 sales grew 5% driven by higher demand in the U.S., partially offset by shipment timing in China. WELIREG sales increased 78% driven by increased uptake in VHL-associated tumors.
Merck had a successful fiscal 2020 with sales increased by 12.9% to € 22,232 million. We want to become the global 21st century science and technology pioneer, working toward an ambitious future: sustainable progress for humankind.